Innovative Biologics Platform Zea Biosciences specializes in plant-based biologics for pharmaceutical applications, offering unique product development capabilities that could appeal to companies seeking sustainable and innovative biotechnology solutions.

Strategic Academic Partnerships Their recent licensing agreement with the University of Pennsylvania and the University of Florida indicates a collaborative approach to advancing biologics and vaccine development, presenting opportunities to connect with academic institutions or leverage joint research initiatives.

Market Recognition Being a finalist in Fast Company's 2022 World Changing Ideas highlights the company's innovative approach and potential to attract customers and investors interested in forward-thinking, environmentally conscious biotech solutions.

Growth Potential With revenue in the lower millions but operating in a $400 billion market, Zea Biosciences presents opportunities to expand their product offerings and customer base within the rapidly growing plant biologics and wellness sectors.

Technology and Data Analytics Their focus on proprietary technology and superior data analytics provides a competitive edge that can be leveraged to attract pharma and biotech clients seeking data-driven, plant-based medicinal products.